Ana M Contreras

Summary

Publications

  1. ncbi request reprint [Viral hepatitis C in patients with renal disease]
    Ana M Contreras
    Departamento de Investigación y Nefrología, Centro Medico Nacional de Occidente, 44280 Guadalajara, Jal
    Rev Gastroenterol Mex 67:S88-92. 2002
  2. ncbi request reprint [Nosocomial transmission of hepatitis C associated with anesthesia procedures: a case-control study]
    Ana M Contreras
    Centro Medico Nacional de Occidente, Instituto Mexicano del Seguro Social, Mexico
    Salud Publica Mex 53:S19-25. 2011
  3. ncbi request reprint [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors]
    Ana M Contreras
    Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Hospital de Especialidades, Centro Medico Nacional de Occidente, Instituto Mexicano del Seguro Social, Mexico
    Salud Publica Mex 53:S13-8. 2011
  4. doi request reprint High antibody level: an accurate serologic marker of viremia in asymptomatic people with hepatitis C infection
    Ana M Contreras
    Health Research Council in Jalisco State, Mexican Institute of Social Security, Jardines Vallarta, Zip Code 45120, Zapopan, Jalisco, Mexico
    Transfusion 50:1335-43. 2010
  5. doi request reprint Very low hepatitis C antibody levels predict false-positive results and avoid supplemental testing
    Ana M Contreras
    Health Research Council in Jalisco State, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico
    Transfusion 48:2540-8. 2008
  6. ncbi request reprint Hepatitis C antibody intraassay correlation: is retest in duplicate necessary?
    Ana M Contreras
    Health Research Council in Jalisco State, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico
    Transfusion 47:1686-90. 2007
  7. ncbi request reprint End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage
    Ana M Contreras
    Jalisco State Coordination of Health Research, Instituto Mexicano del Seguro Social Guadalajara, Mexico
    Ann Hepatol 6:48-54. 2007
  8. ncbi request reprint [False and true positive HCV antibody. Diagnostic strategies]
    Ana Maria Contreras
    UMAE, Hospital de Especialidades CMNO, Delegación Jalisco del Instituto Mexicano del Seguro Social
    Rev Invest Clin 58:153-60. 2006
  9. ncbi request reprint [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ]
    Ana M Contreras
    Departamento de Salud Publica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara y Departamento de Medicina Interna, Hospital de Especialidades, Centro Medico Nacional de Occidente, IMSS, Zapopan, Jal
    Rev Invest Clin 64:641-78. 2012
  10. ncbi request reprint Drug-related hepatotoxicity in a renal transplant recipient with long-term survival and hepatitis C
    Ana M Contreras
    Jalisco State Coordination of Health Research, Instituto Mexicano del Seguro Social Guadalajara, Mexico
    Ann Hepatol 6:70-3. 2007

Collaborators

Detail Information

Publications11

  1. ncbi request reprint [Viral hepatitis C in patients with renal disease]
    Ana M Contreras
    Departamento de Investigación y Nefrología, Centro Medico Nacional de Occidente, 44280 Guadalajara, Jal
    Rev Gastroenterol Mex 67:S88-92. 2002
    ..Chronic hepatitis C without cirrhosis is not a contraindication for renal transplant, but cirrhosis is. Liver failure is the cause of death in 8-28% of renal transplant recipients infected with hepatitis C virus...
  2. ncbi request reprint [Nosocomial transmission of hepatitis C associated with anesthesia procedures: a case-control study]
    Ana M Contreras
    Centro Medico Nacional de Occidente, Instituto Mexicano del Seguro Social, Mexico
    Salud Publica Mex 53:S19-25. 2011
    ..Nosocomial transmission of hepatitis C virus (HCV) infection had been related with anesthesia procedures. The study aim was to measure the association between anesthesia procedures in cases with previous surgery and HCV infection...
  3. ncbi request reprint [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors]
    Ana M Contreras
    Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Hospital de Especialidades, Centro Medico Nacional de Occidente, Instituto Mexicano del Seguro Social, Mexico
    Salud Publica Mex 53:S13-8. 2011
    ..To determine the prevalence of viral infections (HBV, HCV and HIV) in serological window period in blood donors screened with nucleic acid testing (NAT)...
  4. doi request reprint High antibody level: an accurate serologic marker of viremia in asymptomatic people with hepatitis C infection
    Ana M Contreras
    Health Research Council in Jalisco State, Mexican Institute of Social Security, Jardines Vallarta, Zip Code 45120, Zapopan, Jalisco, Mexico
    Transfusion 50:1335-43. 2010
    ..Because a high anti-HCV level has been associated with viremia, a study was conducted to determine whether a high antibody level is an accurate serologic marker for viremia in asymptomatic anti-HCV-positive persons...
  5. doi request reprint Very low hepatitis C antibody levels predict false-positive results and avoid supplemental testing
    Ana M Contreras
    Health Research Council in Jalisco State, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico
    Transfusion 48:2540-8. 2008
    ....
  6. ncbi request reprint Hepatitis C antibody intraassay correlation: is retest in duplicate necessary?
    Ana M Contreras
    Health Research Council in Jalisco State, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico
    Transfusion 47:1686-90. 2007
    ....
  7. ncbi request reprint End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage
    Ana M Contreras
    Jalisco State Coordination of Health Research, Instituto Mexicano del Seguro Social Guadalajara, Mexico
    Ann Hepatol 6:48-54. 2007
    ..To what extent the serum levels of alanine aminotransferase (ALT) are related to histological characteristics of liver damage caused by hepatitis C virus (HCV) infection among patients with end-stage renal disease (ESRD) remains unclear...
  8. ncbi request reprint [False and true positive HCV antibody. Diagnostic strategies]
    Ana Maria Contreras
    UMAE, Hospital de Especialidades CMNO, Delegación Jalisco del Instituto Mexicano del Seguro Social
    Rev Invest Clin 58:153-60. 2006
  9. ncbi request reprint [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ]
    Ana M Contreras
    Departamento de Salud Publica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara y Departamento de Medicina Interna, Hospital de Especialidades, Centro Medico Nacional de Occidente, IMSS, Zapopan, Jal
    Rev Invest Clin 64:641-78. 2012
    ....
  10. ncbi request reprint Drug-related hepatotoxicity in a renal transplant recipient with long-term survival and hepatitis C
    Ana M Contreras
    Jalisco State Coordination of Health Research, Instituto Mexicano del Seguro Social Guadalajara, Mexico
    Ann Hepatol 6:70-3. 2007
    ..In conclusion, hepatotoxic drugs should be used with caution in renal transplant recipients and close monitoring of liver function in patients with chronic viral hepatitis is crucial...
  11. ncbi request reprint Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients
    Jorge Andrade-Sierra
    Department of Nephrology and Transplant Unit, Specialties Hospital, West National Medical Center, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico
    Arch Med Res 37:961-6. 2006
    ..We report the incidence and risk factors associated with the development of PTDM in Mexican kidney recipients...